Established in 1998 and hosted by the World Health Organization (WHO), Stop TB is a partnership that aims to provide global leadership, strategy, and coordinating mechanisms. The Stop TB priorities are to expand, adapt, and improve strategies to control and eliminate TB in support of the World Health Assembly Targets set by 2005 (70% case-detection and 85% cure-rates), and the Millennium Development Goals. The mission is to ensure that every TB patient has access to TB treatment and cure, to protect vulnerable populations from TB and to reduce the social and economic toll that TB exerts on families, communities, and nations. The partnership develops advocacy and resource mobilization strategies in support of these priorities, and coordinates and ‘brokers' resource flows. Other partners in this program include the International Federation of Pharmaceutical Manufactu-rers and Associations (IFPMA), WHO, Eli Lilly, Wyeth and Médecins Sans Frontières (MSF).